Literature DB >> 29129154

Predictors of Drug-Resistant Epilepsy in Tuberous Sclerosis Complex.

Anna Jeong1, Jo Anne Nakagawa2, Michael Wong1,3.   

Abstract

Utilizing the multicenter TSC (tuberous sclerosis complex) Natural History Database including 2034 subjects, this study aimed to identify predictors of drug-resistant epilepsy in TSC. Basic epilepsy data were available for 1965 individuals in the database. Supplemental data were further collected from 1546 of these subjects through directed site queries, addressing additional epilepsy characteristics including the presence of drug-resistant epilepsy, therapies trialed, and outcomes of specific therapies. Epilepsy was reported in 86.4% of individuals with TSC. Infantile spasms were reported in 45.2% of individuals and focal seizures were reported in 84.4% of individuals. In those with focal epilepsy, drug resistance was reported in 59.6%, with focal seizure onset prior to age 1 year (odds ratio [OR] 1.9, confidence interval [CI] 1.4-2.5, P < .001), infantile spasms (OR 2.0, CI 1.5-2.5, P < 0.001), and infantile spasms incompletely responsive to therapy (OR 47.6, CI 6.7-333.3, P < 0.001) being associated with an increased likelihood of drug resistance.

Entities:  

Keywords:  epilepsy; infantile spasms; refractory; seizures; tuberous sclerosis complex

Mesh:

Year:  2017        PMID: 29129154      PMCID: PMC5773119          DOI: 10.1177/0883073817737446

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  27 in total

1.  Long-term neurological outcome in children with early-onset epilepsy associated with tuberous sclerosis.

Authors:  Raffaella Cusmai; Romina Moavero; Roberta Bombardieri; Federico Vigevano; Paolo Curatolo
Journal:  Epilepsy Behav       Date:  2011-12       Impact factor: 2.937

Review 2.  The tuberous sclerosis complex.

Authors:  Peter B Crino; Katherine L Nathanson; Elizabeth Petri Henske
Journal:  N Engl J Med       Date:  2006-09-28       Impact factor: 91.245

3.  Identification of risk factors for autism spectrum disorders in tuberous sclerosis complex.

Authors:  A L Numis; P Major; M A Montenegro; D A Muzykewicz; M B Pulsifer; E A Thiele
Journal:  Neurology       Date:  2011-03-15       Impact factor: 9.910

4.  Developmental outcome after epilepsy surgery in infancy.

Authors:  Tobias Loddenkemper; Katherine D Holland; Lisa D Stanford; Prakash Kotagal; William Bingaman; Elaine Wyllie
Journal:  Pediatrics       Date:  2007-05       Impact factor: 7.124

5.  On the incidence of fits and mental retardation in tuberous sclerosis.

Authors:  D W Webb; A E Fryer; J P Osborne
Journal:  J Med Genet       Date:  1991-06       Impact factor: 6.318

6.  Identification and characterization of the tuberous sclerosis gene on chromosome 16.

Authors: 
Journal:  Cell       Date:  1993-12-31       Impact factor: 41.582

7.  Severity of manifestations in tuberous sclerosis complex in relation to genotype.

Authors:  Sanjeev V Kothare; Kanwaljit Singh; Jason R Chalifoux; Brigid A Staley; Howard L Weiner; Kimberly Menzer; Orrin Devinsky
Journal:  Epilepsia       Date:  2014-06-10       Impact factor: 5.864

8.  The natural history of epilepsy in tuberous sclerosis complex.

Authors:  Catherine J Chu-Shore; Philippe Major; Susana Camposano; David Muzykewicz; Elizabeth A Thiele
Journal:  Epilepsia       Date:  2009-12-22       Impact factor: 5.864

Review 9.  Autism and tuberous sclerosis.

Authors:  S L Smalley
Journal:  J Autism Dev Disord       Date:  1998-10

10.  Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference.

Authors:  Darcy A Krueger; Hope Northrup
Journal:  Pediatr Neurol       Date:  2013-10       Impact factor: 3.372

View more
  6 in total

1.  Current Principles in the Management of Drug-Resistant Epilepsy.

Authors:  Nathan A Shlobin; Josemir W Sander
Journal:  CNS Drugs       Date:  2022-05-20       Impact factor: 6.497

2.  Ketogenic Diet Therapy for Drug-Resistant Epilepsy and Cognitive Impairment in Children With Tuberous Sclerosis Complex.

Authors:  Yu Fang; Dan Li; Man Wang; Xia Zhao; Jing Duan; Qiang Gu; Baomin Li; Jian Zha; Daoqi Mei; Guangbo Bian; Man Zhang; Huiting Zhang; Junjie Hu; Liu Yang; Lifei Yu; Hua Li; Jianxiang Liao
Journal:  Front Neurol       Date:  2022-05-24       Impact factor: 4.086

3.  Early developmental electroencephalography abnormalities, neonatal seizures, and induced spasms in a mouse model of tuberous sclerosis complex.

Authors:  Nicholas Rensing; Kevin J Johnson; Thomas J Foutz; Joseph L Friedman; Rafael Galindo; Michael Wong
Journal:  Epilepsia       Date:  2020-04-10       Impact factor: 6.740

4.  Establishment of a Regional Interdisciplinary Medical System for Managing Patients with Tuberous Sclerosis Complex (TSC).

Authors:  Ayataka Fujimoto; Tohru Okanishi; Shin Imai; Masaaki Ogai; Akiko Fukunaga; Hidenori Nakamura; Keishiro Sato; Akira Obana; Takayuki Masui; Yoshifumi Arai; Hideo Enoki
Journal:  Sci Rep       Date:  2018-11-13       Impact factor: 4.379

Review 5.  Risk Factors Associated with Refractory Epilepsy in Patients with Tuberous Sclerosis Complex: A Systematic Review.

Authors:  Dominika Miszewska; Monika Sugalska; Sergiusz Jóźwiak
Journal:  J Clin Med       Date:  2021-11-24       Impact factor: 4.241

6.  Prediction of Neurodevelopment in Infants With Tuberous Sclerosis Complex Using Early EEG Characteristics.

Authors:  Jessie De Ridder; Mario Lavanga; Birgit Verhelle; Jan Vervisch; Katrien Lemmens; Katarzyna Kotulska; Romina Moavero; Paolo Curatolo; Bernhard Weschke; Kate Riney; Martha Feucht; Pavel Krsek; Rima Nabbout; Anna C Jansen; Konrad Wojdan; Dorota Domanska-Pakieła; Magdalena Kaczorowska-Frontczak; Christoph Hertzberg; Cyrille H Ferrier; Sharon Samueli; Barbora Benova; Eleonora Aronica; David J Kwiatkowski; Floor E Jansen; Sergiusz Jóźwiak; Sabine Van Huffel; Lieven Lagae
Journal:  Front Neurol       Date:  2020-10-16       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.